| Record ID | marc_loc_2016/BooksAll.2016.part29.utf8:239748969:985 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part29.utf8:239748969:985?format=raw |
LEADER: 00985cam a22002774a 4500
001 2002284783
003 DLC
005 20050822180641.0
008 020724s2000 ctua s 000 0 eng
010 $a 2002284783
020 $a1569655871
040 $aDLC$cDLC
042 $apcc
043 $an-us---
050 00 $aHD9675.O753$bU622 2000
245 00 $aBones and joints :$bdrugs, devices, and regenerative technologies /$cSteve Alan Edwards, project analyst.
260 $aNorwalk, CT :$bBusiness Communications Co.,$cc2000.
300 $axix, 198, [11] leaves :$bill. ;$c28 cm.
440 0 $aBusiness opportunity report ;$vB-143
500 $a"January 2001"--T.p. verso.
650 0 $aOsteoporosis drug industry$zUnited States.
650 0 $aAntiarthritic agents industry$zUnited States.
650 0 $aBones$xDiseases$xTreatment$zUnited States.
650 0 $aMarket surveys$zUnited States.
700 1 $aEdwards, Steven A.$q(Steven Alan),$d1951-
710 2 $aBusiness Communications Co.